Skip to main content
. Author manuscript; available in PMC: 2009 May 6.
Published in final edited form as: J Infect Dis. 2008 Nov 1;198(9):1334–1336. doi: 10.1086/592282

Table 2.

Distribution of GM 3-carrier and GM 23-carrier genotypes, in relation to persistence of hepatitis C virus (HCV) infection and clearance of HCV.

Subjects, no. (%)a
Genotype, status Persistent HCV infection Cleared HCV OR (95% CI) P
GM3
    Carriers 100 (95.2) 97 (85.1) 3.50 (1.24−9.87) .01
    Noncarriers 5 (4.8) 17 (14.9)
GM23
    Carriers 78 (71.6) 77 (64.7) 1.37 (0.78−2.40) .32
    Noncarriers 31 (28.4) 42 (35.3)

NOTE. CI, confidence interval; OR, odds ratio.

a

Because of typing failures, totals do not sum to 111, in the case of persistent HCV infection, or to 119, in the case of cleared HCV.